References
- 1Kolahdouzan M, Hamadeh MJ. The neuroprotective effects of caffeine in neurodegenerative diseases. CNS Neurosci Ther. 2017; 23(4): 272–90. DOI: 10.1111/cns.12684
- 2Dhaenens CM, Burnouf S, Simonin C, Van Brussel E, Duhamel A, Defebvre L, et al. A genetic variation in the ADORA2 A gene modifies age at onset in Huntington’s disease. Neurobiol Dis. 2009; 35(3): 474–6. DOI: 10.1016/j.nbd.2009.06.009
- 3Taherzadeh-Fard E, Saft C, Wieczorek S, Epplen JT, Arning L. Age at onset in Huntington’s disease: replication study on the associations of ADORA2 A, HAP1 and OGG1. Neurogenetics. 2010; 11(4): 435–9. DOI: 10.1007/s10048-010-0248-3
- 4Mievis S, Blum D, Ledent C. A2 A receptor knockout worsens survival and motor behaviour in a transgenic mouse model of Huntington’s disease. Neurobiol Dis. 2011; 41(2): 570–6. DOI: 10.1016/j.nbd.2010.09.021
- 5Chou SY, Lee YC, Chen HM, Chiang MC, Lai HL, Chang HH, et al. CGS21680 attenuates symptoms of Huntington’s disease in a transgenic mouse model. J Neurochem. 2005; 93(2): 310–20. DOI: 10.1111/j.1471-4159.2005.03029.x
- 6Chiang MC, Chen HM, Lai HL, Chen HW, Chou SY, Chen CM, et al. The A2 A adenosine receptor rescues the urea cycle deficiency of Huntington’s disease by enhancing the activity of the ubiquitin-proteasome system. Hum Mol Genet. 2009; 18(16): 2929–42. DOI: 10.1093/hmg/ddp230
- 7Mishra J, Kumar A. Improvement of mitochondrial NAD(+)/FAD(+)-linked state-3 respiration by caffeine attenuates quinolinic acid induced motor impairment in rats: implications in Huntington’s disease. Pharmacol Rep. 2014; 66(6): 1148–55. DOI: 10.1016/j.pharep.2014.07.006
- 8Brunquell J, Morris S, Snyder A, Westerheide SD. Coffee extract and caffeine enhance the heat shock response and promote proteostasis in an HSF-1-dependent manner in Caenorhabditis elegans. Cell Stress Chaperones. 2018; 23(1): 65–75. DOI: 10.1007/s12192-017-0824-7
- 9Simonin C, Duru C, Salleron J, Hincker P, Charles P, Delval A, et al. Association between caffeine intake and age at onset in Huntington’s disease. Neurobiol Dis. 2013; 58: 179–82. DOI: 10.1016/j.nbd.2013.05.013
- 10Shoulson I, Fahn S. Huntington disease: clinical care and evaluation. Neurology. 1979; 29(1): 1–3. DOI: 10.1212/WNL.29.1.1
- 11Mitchell DC, Knight CA, Hockenberry J, Teplansky R, Hartman TJ. Beverage caffeine intakes in the U.S. Food Chem Toxicol. 2014; 63: 136–42. DOI: 10.1016/j.fct.2013.10.042
- 12Kantar Worldpanel Online Data Delivery and Analysis Tool. Available at:
https://www.kantarworldpanel.com/global/Countries . - 13Mitchell DC, Knight CA, Hockenberry J, Teplansky R, Hartman TJ. Beverage caffeine intakes in the U.S. Food Chem Toxicol. 2014; 63: 136–142. DOI: 10.1016/j.fct.2013.10.042
- 14Food Insight. Caffeine: Consumer Consumption Habits and Safety Perceptions [Internet]. [updated date – 2022 March 15; cited – 2023 July 10]. Available from:
https://foodinsight.org/wp-content/uploads/2022/03/IFIC-Caffeine-Survey.March-2022.pdf . - 15Mahoney CR, Giles GE, Marriott BP, Judelson DA, Glickman EL, Geiselman PJ, Lieberman HR. Intake of caffeine from all sources and reasons for use by college students. Clinical nutrition. 2019; 38(2): 668–675. DOI: 10.1016/j.clnu.2018.04.004
- 16Oosterloo M, Craufurd D, Nijsten H, & van Duijn E. Obsessive-Compulsive and Perseverative Behaviors in Huntington’s Disease. Journal of Huntington’s disease. 2019; 8(1): 1–7. DOI: 10.3233/JHD-180335
- 17De Marchi N, Mennella R. Huntington’s disease and its association with psychopathology. Harvard review of psychiatry. 2000; 7(5): 278–289. DOI: 10.1093/hrp/7.5.278
- 18Hughes SB, Churchill E, Smirnova A, Hall A, Culbert B, Snell C, Wright BA, Gilbert PE, Corey-Bloom J. Anosognosia in HD: Comparison of self-report and caregiver ratings with objective performance measures. Parkinsonism & related disorders. 2023; 107,
105272 . DOI: 10.1016/j.parkreldis.2022.105272 - 19Huntington Study Group (Kieburtz K, primary author). The Unified Huntington’s Disease Rating Scale: Reliability and Consistency. Mov Dis. 1996; 11: 136–142. DOI: 10.1002/mds.870110204
- 20Maier W, Buller R, Philipp M, Heuser I. The Hamilton Anxiety Scale: reliability, validity and sensitivity to change in anxiety and depressive disorders. J Affect Disord. 1988; 14(1): 61. DOI: 10.1016/0165-0327(88)90072-9